Invitation to presentation in connection with EQL Pharma's interim report, first quarter, 2025/26
EQL Pharma AB (publ) will publish its interim report for the first quarter, 2025/26, on Friday, August 8[th], before stock markets open.
Media
Here you can take part in regulatory and non-regulatory press releases and presentations.
Read More
Press Releases
Notice of annual general meeting in EQL Pharma AB
Regulatory
The shareholders of EQL Pharma AB, Reg. No. 556713-3425, are hereby invited to the annual general meeting to be held on Thursday 21 August 2025 at 16.00 at the company’s premises at Stortorget 1 in...
EQL takes first step to establish itself in Germany and the Netherlands
EQL has now taken the first step to establish itself in Germany and the Netherlands by recruiting key people with knowledge of the local markets who can identify, develop/in-license and launch nich...